Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
   M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
   M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
   M03 MUSCLE RELAXANTS
   M04 ANTIGOUT PREPARATIONS
   M05 DRUGS FOR TREATMENT OF BONE DISEASES
     M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
       M05BA Bisphosphonates [DG:DG01600]
       M05BB Bisphosphonates, combinations
       M05BC Bone morphogenetic proteins
       M05BX Other drugs affecting bone structure and mineralization
         M05BX01 Ipriflavone
         M05BX02 Aluminium chlorohydrate [DG:DG00431]
         M05BX03 Strontium ranelate
         M05BX04 Denosumab
         M05BX05 Burosumab
           D10913  Burosumab (USAN/INN) <US>
         M05BX06 Romosozumab
         M05BX53 Strontium ranelate and colecalciferol
   M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 22, 2019
According to WHO's ATC 2019

» Japanese version